Protalix BioTherapeutics, Inc. Adjustments to Additional Paid in Capital, Other
Protalix BioTherapeutics, Inc. (PLX) reported Adjustments to Additional Paid in Capital, Other of $43.63 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-12.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2020-03-12
- Protalix BioTherapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2017-12-31 was $0.00.
- Protalix BioTherapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2017-09-30 was $0.00.
- Protalix BioTherapeutics, Inc. adjustments to additional paid in capital, other for fiscal 2017 was $43.63M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $43.63M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $43.63M 10-Q · filed 2019-03-18 | ||
| 2017-06-30 | $43.63M 10-Q · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |